Information Journal Paper
APA:
Copy. (2018). Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARalpha agonist) in smokers. PLOS ONE, 13(9), 0-0. SID. https://sid.ir/paper/734146/en
Vancouver:
Copy. Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARalpha agonist) in smokers. PLOS ONE[Internet]. 2018;13(9):0-0. Available from: https://sid.ir/paper/734146/en
IEEE:
Copy, “Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARalpha agonist) in smokers,” PLOS ONE, vol. 13, no. 9, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/734146/en